Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford IBD MasterClass 2024

Immunology and Immuno-Modulatory Therapy in Inflammatory Bowel Disease: Bench to Bedside

MasterClass Logo

Dates: 23rd - 24th September 2024, at the Examinations Schools, Oxford, UK

 

Oxford MasterClass 2024 Organising Committee: Jack Satsangi, Paul Klenerman, Holm Uhlig, Simon Leedham, Alessandra Geremia, Denise O’Donnell & Lydia White.

 

The Oxford MasterClass 2024 will be held on 23rd - 24th September at the Examination Schools in Oxford.  The focus of the meeting will be the innovations in IBD from the field of immunology.  As always, the meeting will be delivered by a distinguished faculty of national and international speakers. 

 

 

SPONSORS

The Oxford MasterClass 2022 would like to warmly thank and acknowledge the contributions from our sponsors.

This meeting is supported by sponsorship contributions from various pharmaceutical companies who have had no input into the development and content of the meeting.

To view our sponsors please click here or the link in the menu.

 

ACCREDITATION

Oxford Masterclass 2022 has applied for CPD points/credits from The Federation of the Royal College of Physicians of the United Kingdom.  Further details about the number of points allocated will be shared in due course. 

We do hope you will join us in Oxford, for what will be a stimulating and enlightening 2-day event. 

 

REGISTRATION

 

TBA

 

COVID

Our plan is for this to be an in-person event, with all the benefits of networking opportunities and face-to-face interactions that this brings. We will continue to follow the latest government guidance on the COVID-19 pandemic and share any changes that may impact this face-to-face event with delegates and potential attendees as soon as possible. 

In this section